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The Safety and Outcomes
of Chronic Total
Occlusion Interventions*
Brigitta C. Brott, MD
Birmingham, Alabama
The percutaneous treatment of chronic total occlusions
(CTO) is often viewed as one of the remaining frontiers of
interventional cardiology. It remains a challenging proce-
dure, associated with increased risk of significant complica-
tions. Chronic total occlusions are present in approximately
15% of patients referred for cardiac catheterization and in
approximately 23% of those with multivessel or left main
disease, and attempted percutaneous revascularization
rates are low at approximately 13% (1,2). In addition,
many cardiologists favor medical therapy of these lesions
with referral for coronary artery bypass grafting (CABG)
for refractory symptoms, because these lesions are by
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definition categorized as stable coronary artery disease.
Therefore, they consider CTO patients in the same group as
those treated in the COURAGE (Clinical Outcomes Uti-
lizing Revascularization and Aggressive Drug Evaluation)
trial (3). This approach has recently been challenged by a
meta-analysis of 7,182 patients with stable coronary artery
disease comparing optimal medial therapy and percutaneous
coronary intervention (PCI), which found greater angina
relief both short- and long-term (4). More importantly, in
the COURAGE trial, those with moderate to large regions
of ischemia demonstrated a survival benefit with percutane-
ous treatment (5).
Reasons to pursue percutaneous revascularization of
CTOs include the potential for a reduction in angina
symptoms, improved quality of life and functional status, a
reduced need for CABG, and better long-term survival
(1,6,7). A recent meta-analysis by Joyal et al. (7) addressed
outcomes of patients who underwent successful versus
unsuccessful CTO intervention. Although no randomized
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am, Alabama. Dr. Brott is co-founder of Endomimetics, LLC.trials were found, 13 observational studies comparing PCI
with planned medical therapy were included. This analysis
demonstrated a survival benefit for those who underwent
recanalization (14.3% vs. 17.5%, odds ratio [OR]: 0.56).
There was a reduction in need for subsequent CABG (OR:
0.22) and, in the 6 studies that reported angina status, a
reduction in residual/recurrent angina (OR: 0.45). In addi-
tion, in those patients with left ventricular dysfunction and
demonstrated viability in the region of the CTO, recanali-
zation might improve left ventricular function and regional
wall motion (8,9). Despite the common perception that
well-developed collaterals are protective, collateral flow
reserve assessment has demonstrated that collateral flow is
usually inadequate to prevent ischemia during stress (10).
Potential explanations for the improved survival in those
undergoing recanalization include improvement in left ven-
tricular function, reduced predisposition to ventricular ar-
rhythmias, or improved survival in the setting of an acute
myocardial infarction due to occlusion of another vessel (1).
Thus, consensus documents recommend consideration of
CTO PCI if the patient is symptomatic from the CTO (or
if a large region of ischemia/viability is present), the myo-
cardium supplied is viable, the likelihood of success is
60%, and the anticipated major complication rate is low
(11–13).
The interventional approach to CTOs is rapidly evolving,
with an increasing emphasis on dedicated operator and staff
training, development of CTO centers, and flourishing
training courses and CTO clubs. Operator training, expe-
rience, and technique are crucial for procedural success and
minimization of complications (14). In a registry of 636
CTO procedures, those operators with experience and
frequent use of the retrograde technique had a significantly
greater technical success rate compared with low-volume
CTO operators (75.2% vs. 58.9%, p  0.0001) (14). Thus,
a detailed understanding is required of guide catheter use,
wire selection, wire re-entry techniques, antegrade and
retrograde approaches, and specialist equipment (15).
In this issue of JACC: Cardiovascular Interventions, Patel
et al. (16) report a meta-analysis of registries and case series
describing procedural complications of CTO PCI and
demonstrate high technical success with low complication
rates. We know from the Japanese experience that CTO
PCI can be performed safely with high success rates, but
this is the first meta-analysis to address complications in a
broader range of centers. An experience of 18,071 patients
undergoing PCI of 18,941 CTO lesions is described. It is
striking that, in a wider array of procedural experience, the
success rate is high at 77%, with low rates of death,
emergent CABG, and stroke. Additionally, with 886 lesions
treated with a retrograde approach, the success rate was
79.8% with no deaths and low risk of emergent CABG and
tamponade. Of note, those who underwent an unsuccessful
CTO PCI attempt had higher rates of death, stroke,
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138coronary perforation, and tamponade. This is not unex-
pected, given that CTO PCI often requires the use of
aggressive wires that can cause dissection and perforation
and cannulation of collateral vessels that can cause ischemia
and loss of collateral flow.
These are promising results, demonstrating safe and
effective expansion of complex techniques beyond a few
isolated centers. Still, operator CTO volume and experience
play a large role in outcomes (14), and—as the authors
indicate—individual operator experience is not available for
this particular analysis. To address the issue of operator
volume, the authors used case series as a surrogate for
operator volume and did not find a difference in outcomes
between small series and large ones. However, as they point
out, some of the small case studies were reported by groups
known to have a high CTO volume; thus this is a poor
surrogate. Additionally, publication bias is particularly an
issue in an analysis such as this, in that those with poor
results are less likely to report their outcomes. Nevertheless,
we know that CTO interventions can be performed safely
with a high rate of technical success, supporting the expan-
sion of these procedures to those centers willing to make the
commitment of training and meticulous technique required
for these challenging procedures.
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